The Schwab U.S. Dividend Equity ETF (SCHD), which tracks high-dividend U.S. stocks in the Dow Jones U.S. Dividend 100 Index, gained 0.43% in pre-ma......

The Schwab U.S. Dividend Equity ETF (SCHD), which tracks high-dividend U.S. stocks in the Dow Jones U.S. Dividend 100 Index, lost 0.03% in pre-mark......

JonesTrading analyst Soumit Roy maintained a Buy rating on Oric Pharmaceuticals today and set a price target of $25.00. Roy covers the Healthcare s......

The Schwab U.S. Dividend Equity ETF (SCHD), which tracks high-dividend U.S. stocks in the Dow Jones U.S. Dividend 100 Index, closed 0.16% higher on......

Which stocks are best to buy now amid the recent market pullback? According to Top Wall Street Analysts, the three stocks listed below are Strong B......

The Schwab U.S. Dividend Equity ETF (SCHD), which tracks high-dividend U.S. stocks in the Dow Jones U.S. Dividend 100 Index, lost 0.23% in pre-mark......

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Diamedica Therapeutics (DMAC), Elevance Health (ELV) and Oric Pha......

The Schwab U.S. Dividend Equity ETF (SCHD), which tracks high-dividend U.S. stocks in the Dow Jones U.S. Dividend 100 Index, lost 0.20% in pre-mark......

An announcement from Oric Pharmaceuticals ( ($ORIC) ) is now available. On March 31, 2026, ORIC Pharmaceuticals presented an update on dose optimiz......

The latest update is out from Orica Limited ( ($AU:ORI) ). Orica Limited has reduced its issued capital through the cancellation of 1,344,290 ordin......